Canlyniadau Chwilio - David Tougeron

Mireinio'r Canlyniadau
  1. 1
    Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies

    Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies gan Violaine Randrian, Camille Evrard, David Tougeron

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    ABCB4/MDR3 gene mutations and cholangiocarcinomas

    ABCB4/MDR3 gene mutations and cholangiocarcinomas gan David Tougeron, Ginette Fotsing, Véronique Barbu, Michel Beauchant

    Cyhoeddwyd 2012
    Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Irreversible electroporation and electrochemotherapy in oncology: State of the art

    Irreversible electroporation and electrochemotherapy in oncology: State of the art gan Jean‐Pierre Tasu, David Tougeron, Marie‐Pierre Rols

    Cyhoeddwyd 2022
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Aspirin and Colorectal Cancer: Back to the Future

    Aspirin and Colorectal Cancer: Back to the Future gan David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer

    Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer gan Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan‐Tapon, David Tougeron

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells

    Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells gan Jae Myung Park, David Tougeron, Shengbing Huang, Koichi Okamoto, Frank A. Sinicrope

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment

    Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment gan Julien Taı̈eb, Magali Svrcek, Romain Cohen, Debora Basile, David Tougeron, Jean-Marc Phélip

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer

    High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer gan Marion Jeantet, David Tougeron, Gaëlle Tachon, Ulrich Cortes, Céline Archambaut, Gaëlle Fromont, Lucie Karayan‐Tapon

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer

    Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer gan David Tougeron, F. Di Fiore, S. Thureau, N. Berbera, Isabelle Iwanicki–Caron, H. Hamidou, B Paillot, Pierre Michel

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial

    Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial gan S. Ganame, T. Walter, A. Durand, Astrid Lièvre, David Tougeron, Jean–Yves Scoazec, E. Baudin, C. Lepage, Olayidé Boussari, Julien Hadoux

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐based chemotherapy

    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... gan Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

    Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer gan David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès, Claire Villalva, Christine Collin, Aurélie Ferru, J.M. Tourani, Christine Silvain, P. Levillain, L. Karayan-Tapon

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas

    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas gan Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

    Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor gan Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard‐Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study

    COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study gan Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

    Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study gan Maëva Salimon, Caroline Prieux‐Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak‐Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan, Yann Touchefeu

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    “Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial”

    “Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial” gan Julien Taı̈eb, Léonor Benhaïm, Pierre Laurent–Puig, Karine Le Malicot, Jean‐François Emile, Flore Geillon, David Tougeron, Sylvain Manfrédi, Marion Chauvenet, Valérie Taly, Côme Lepage, Thierry André

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer

    Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer gan Isabelle Iwanicki–Caron, Frédéric Di Fiore, Isabelle Roque, Emilie Astruc, Monica Stetiu, A. Duclos, David Tougeron, Sandrine Saillard, S. Thureau, Jacques Bénichou, B Paillot, J P Basuyau, Pierre Michel

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    <i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

    <i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) gan Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... gan Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: